The genetic spectrum of familial hypercholesterolemia in Pakistan
Open Access
- 1 June 2013
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 421, 219-225
Abstract
No abstract availableKeywords
Funding Information
- British Heart Foundation (RG008/08)
- Higher Education Commission of Pakistan (934)
- Shifa College of Medicine
- IRSIP
This publication has 25 references indexed in Scilit:
- Novel Loss-of-Function PCSK9 Variant Is Associated with Low Plasma LDL Cholesterol in a French-Canadian Family and with Impaired Processing and Secretion in Cell CultureClinical Chemistry, 2011
- A Novel Pathogenic Nonsense Triple-Nucleotide Mutation in the Low-Density Lipoprotein Receptor Gene and Its Clinical Correlation with Familial HypercholesterolemiaGenetic Testing and Molecular Biomarkers, 2011
- Role of tissue plasminogen activator and plasminogen activator inhibitor polymorphism in myocardial infarctionMolecular Biology Reports, 2010
- Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade projectClinical Genetics, 2010
- Mechanisms of Disease: genetic causes of familial hypercholesterolemiaNature Clinical Practice Cardiovascular Medicine, 2007
- Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease riskJournal of Medical Genetics, 2006
- Effect of mutations in the PCSK9 gene on the cell surface LDL receptorsHuman Molecular Genetics, 2006
- Severe Hypercholesterolemia in Four British Families With the D374Y Mutation in the PCSK9 GeneArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- NARC-1/PCSK9 and Its Natural MutantsJournal of Biological Chemistry, 2004
- Characterization and geographic distribution of the low density lipoprotein receptor (LDLR) gene mutations in northwestern GreeceHuman Mutation, 2001